MariMed Inc.
MariMed Inc. (MRMD.CN) Stock Overview
Explore MariMed Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
56.4M
P/E Ratio
-2.50
EPS (TTM)
$-0.05
ROE
-0.25%
MRMD.CN Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of MariMed Inc. (MRMD.CN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of N/A.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -2.50 and a market capitalization of 56.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Company Profile
MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company offers cannabis genetics produce flowers and concentrates under the Nature's Heritage brand; cannabis-infused products in the form of chewable tablets and powder drink mixes under the brand Kalm Fusion; natural fruit chews under the Betty's Eddies brand; brownies, cookies, and other social sweets under the Bubby's Baked brand; and cannabidiol formulations under the Florance brand. It also licenses its brands and product formulations, as well as leases cannabis facilities. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.
Jon R. Levine
715
10 Oceana Way, Norwood, MA
2022